STAT+: Pharmalittle: Moderna must face patent claims over its Covid-19 vaccine; Pfizer and BioNTech testing combo Covid and flu shot
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Category: pharmalittle
.jpg)
STAT+: Pharmalittle: FDA panel urges improved regulation of pulse oximeters; CVS Health agrees to $5 billion settlement over opioid lawsuits
Good morning from San Diego. I’m Jonathan Wosen, STAT’s West Coast biotech reporter, and I’m…
.jpg)
STAT+: Pharmalittle: Pfizer maternal RSV vaccine meets pivotal study’s goal; Lilly cuts its annual profit forecast
Tumble out of bed and stumble to the kitchen, pour myself a cup of ambition,…
STAT+: Pharmalittle: Drugmaker raises price of old chemo med 10-fold amid shortages; Alnylam cites drug-price law in halting trial
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: White House pharma help in plan to combat hepatitis C; J&J blood cancer drug will cost $39,500 a month
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Pharmalittle: Online prescribing prompts scrutiny and concern; FDA is pushed to approve OTC birth control pills
Top of the morning to you. Gray skies are hovering once again over the Pharmalot…
STAT+: Pharmalittle: Merck suddenly finds Ebola vaccine doses in its freezers; drugs studied to combat women’s midlife mood swings
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Pfizer plans to quadruple price of its Covid-19 vaccine; pharma pushed to tie exec compensation to access to meds
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Pharma tries to blunt Medicare power to negotiate prices; FDA panel supports withdrawal of premature birth drug
Top of the morning to you. Another deliciously shiny day is unfolding over the Pharmalot…
STAT+: Pharmalittle: Merck KGaA probed by French court for misleading info; former Genentech scientists given prison terms over trade-secret theft
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Pharmalittle: J&J will cut its workforce; pharma gave Dems money despite threats over Medicare drug-price negotiation
Top of the morning to you. Another busy day is unfolding on the Pharmalot satellite…
STAT+: Pharmalittle: BioNTech eyes cancer vaccine before decade’s end; Pfizer asks Supreme Court to review copay programs
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Biden to sign executive order to push drug costs down; big grocers get bad grades for antibiotic policies
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: GSK vaccine for RSV was effective in study of older adults; Eisai is confident of U.S. approval of its Alzheimer’s drug
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…
STAT+: Pharmalittle: Walmart joins rivals in entering clinical trial work; Maiden Pharma failed to do quality tests on cough syrups
Top of the morning to you, and a fine one it is. After all, there…
STAT+: Pharmalittle: BIO CEO resigns amid board disagreements; Pfizer exec denies allegations over EU Covid-vaccine deal
Good morning, everyone, and how are you today? We are doing just fine thank you,…
STAT+: Pharmalittle: Medicare can still penalize drugmakers for hiking prices to privately insured patients; FDA explains push to withdraw premature-birth drug
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Vertex exec says prices for gene therapies are ‘in the ballpark’; insulin access in poor countries remains spotty
Rise and shine, everyone, another busy day is on the way. And this is especially…
STAT+: Pharmalittle: Nobel awarded for novel chemistry used in drug development; Biden will nominate surgeon general for WHO post
Good morning, Pharmalitte students. I’m Allison DeAngelis, substituting for Ed today. It’s a rainy day…
STAT+: Pharmalittle: U.S. Supreme Court asks solicitor general for views on ‘skinny label’ case; Express Scripts and Kroger are mired in dispute
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: Price of new ALS drug prompts criticism; many drug price hikes exceeded U.S. inflation rate
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: FDA approves a medicine to combat ALS; Medicare drug-price talks are poised to become a legal battle
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Medicare plans sizable infrastructure for negotiating drug prices; Alzheimer’s data also boost Roche and Lilly
Rise and shine, everyone, another busy day is on the way. We can tell by…
STAT+: Pharmalittle: Biogen Alzheimer’s drug slowed cognitive decline in a trial; European pharma warns energy costs may halt some generic production
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: Democrats concede on passing ‘clean’ FDA funding bill; Biogen whistleblower nets $250 million
Good morning, one and all. Damian here, filling in for Ed Silverman once more. Here…
STAT+: Pharmalittle: GSK picks its first female CFO; Pfizer advances Omicron booster for kids
Good morning, everyone. Damian Garde here, filling in for Ed Silverman at the outset of…
STAT+: Pharmalittle: U.S. drug net prices fell nearly 8% in the second quarter; FDA panel favors fecal-based therapy for bacterial infections
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Biogen ALS drug trial yields mixed signals; Novartis makes U.S. growth its top priority
Hello, everyone, and how are you today? A dank cloudy cover greeted us this morning,…
STAT+: Pharmalittle: FDA scolds Catalent over quality control at plant making Covid shots; Novartis will ask SCOTUS to protect a key patent
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Pharmalittle: Haleon argues it’s not liable for any Zantac claims; FDA steps up surprise inspections in India
Top of the morning to you, and a fine one it is. Crystal clear blue…
STAT+: Pharmalittle: Advances in treating the sickest Covid patients have stalled; Moderna aids WHO effort to develop mRNA coronavirus shots
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Swiss authorities probe Novartis over patent used to block rivals; Medicare underserves older Americans with opioid use disorder
Rise and shine, everyone, another busy day is on the way. This morning is getting…
STAT+: Pharmalittle: Pharma pursues the ‘dream’ of online prescribing; EC chief under fire over Pfizer vaccine contract
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Pharmalittle: Biden picks biotech exec to lead new biomedical research agency; FDA to hold meeting for OTC birth control pill
Hello, everyone, and how are you today? The skies over the Pharmalot campus remain gloomy…
STAT+: Pharmalittle: FDA approves new type of psoriasis drug; U.S. starts late-stage trial to test an antiviral against monkeypox
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Illumina faces more challenges after winning FTC case; Novo Nordisk buys Forma Therapeutics
Good morning, everyone. I’m Jason Mast, the last of the understudies filling in while Ed…
STAT+: Pharmalittle: FDA authorizes new Covid boosters; a setback for federal efforts to regulate stem cell clinics
Good morning. This is Jonathan with you once more. We’re now close enough to the…
STAT+: Pharmalittle: An emerging star in biotech investment; U.S. government expected to stop paying for Covid shots next year
Good morning from San Diego. I’m Jonathan Wosen, STAT’s West Coast biotech reporter, and I’m…
STAT+: Pharmalittle: FDA expected to authorize new Covid-19 boosters; Biden administration signs a deal to support monkeypox vaccine manufacturing
Good morning, everyone. I’m Allison DeAngelis, and I’m here to lead you through Tuesday’s news….
STAT+: Pharmalittle: The ‘godfather’ of biotech trying to save Biogen; pharma companies grapple with ADHD drug shortages
Happy Monday, folks — Allison DeAngelis here. Ed is away from the Pharmalot campus this…
STAT+: Pharmalittle: Senate bill would allow insulin makers to lock in profits; GSK, Novartis pledge funds for diseases that mostly affect the poor
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Pharmalittle: U.K. inks $1.2 billion deal with Moderna for vaccine center; Top Biocon exec arrested in bribery scandal
Hello, everyone, and welcome to the middle of the week. You made it this far,…
STAT+: Pharmalittle: Medicare could have saved billions if it paid what Cuban charges; India’s drug controller accused of taking bribe
Top of the morning to you, and a fine one it is. The sun is…
STAT+: Pharmalittle: Merck is eyeing Seagen to beef up its cancer drug portfolio; Lawmakers want GAO to probe PBMs
Good morning, everyone, and welcome to another working week, although today is actually a holiday…
STAT+: Pharmalittle: FDA OKs new type of diabetes drug from Lilly; Early-stage biotechs are juicy targets for M&A surge
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Califf admits Alzheimer’s drug controversy has hurt expert trust in FDA; House passes bill to lower insulin costs
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Advisory panel narrowly votes down ALS drug; Vertex looks to advance experimental pain drug
Good morning. Elizabeth Cooney here, borrowing the virtual Pharmalittle chair while Ed Silverman takes Manhattan…
STAT+: Pharmalittle: Insurers balk at opioid payouts to drugmakers and wholesalers; AbbVie settles another Humira biosimilar lawsuit
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: Francis Collins to step down as NIH director; Research confirms decline in Pfizer vaccine protection against ‘breakthrough’ infection
Good morning, everyone, and how are you today? Gray skies are hovering over the Pharmalot…
STAT+: Pharmalittle: J&J to seek emergency use of Covid-19 vaccine booster; Pfizer loses legal battle over Medicare co-pay programs
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…